Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4952 per EA under NDC 42858032501. Its NADAC has been published 358 times since Oct 16, 2019.
FDA first approved this application on May 17, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHET ER 25 MG CAP
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATEStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858032501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210651FDA Approved
5/17/2019
TE Code
AB1
On Market Since
8/22/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 358 times since Oct 16, 2019, and over the history we have for it it has declined 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4952 per EA |
|---|---|
| All-time high | $1.4626 (Apr 15, 2020) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5709 |
| 52-week low | $0.4896 |
| Median price | $0.6093 |
| Average price | $0.6699 |
| Largest weekly change | -47.3% (Apr 22, 2020) |
| Weeks tracked | 358 |
| Tracking since | Oct 16, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $0.4952 per EA (NDC 42858032501), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 63.0%. It has been tracked across 358 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Oct 16, 2019, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $1.4626 (Apr 15, 2020), with a median of $0.6093 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 42858032501) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.